Physician profile
Sacha A Stanley
NPI 1780399857
$552.77
in general payments reported to CMS, 2019-2025
9 companies · $30.73 in 2025
The $30.73 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $435 · 2024: $86.55 · 2025: $30.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $246.33 | 2023-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $113.31 | 2023-2024 | Tezspire, Farxiga |
| Teva Pharmaceuticals USA, INC. | $52.77 | 2023 | Austedo Xr |
| Glaxosmithkline, LLC. | $32.55 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Kowa Pharmaceuticals America, INC. | $29.32 | 2023 | Seglentis, Livalo |
| Amgen INC. | $25.26 | 2023 | Repatha, Otezla |
| Exact Sciences Corporation | $22.58 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.88 | 2023 | Steglatro |
| Novo Nordisk INC | $13.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sacha Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.